Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
August 3, 2011
DESIO, ItalyGnosis S.p.A will share research on its probiotic yeast Saccahromyces boulardii as a sponsor and participate in the 6th Probiotics, Prebiotics & New Foods" symposium held in Rome Sept.11 to 13, 2011, at the Urbaniana University. This probiotic yeast is commercialized under the probiotic brand name of Biooptima and can be incorporated into dairy, dietary supplements and food products.
Gnosis will present studies on dietary supplementation with Saccahromyces boulardii as a novel strategy to improve metabolic syndrome in an animal model of obesity. Ignazio Castagliuolo, associate professor of Microbiology of Padua University, Italy, will present the findings.
The meeting has been organized under the patronage of Italian Academy for the study of Intestinal Microbiota, SIGE Italian Gastroenterology Society", SINUT - Italian Society of Nutraceuticals, ESPGHAN - European Society for Paediatric Gastroenterology, Hepatology and Nutrition and SIGENP Italian Gastroenterology and Hepatology Society and Paediatric Nutrition.
The International conference, that takes place every two years, brings together speakers to explore recent research and scientific advances related to probiotics, prebiotics and new foods and to address claims substantiation, regulatory and technology issues for innovative industrial applications in these fields.
Biooptima Saccharomyces boulardii is produced under a patent-protected process and advanced drying technologies.
You May Also Like
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024
Formulating the future: The industry may not be ready for AI in product development, and AI might not be ready for the industry, eitherFeb 20, 2024
Beyond the primary outcome: How exploratory analysis can deliver unexpected new insightsFeb 19, 2024
Survey shows dietitians concerned about TikTok misinformationFeb 16, 2024